{"transactions":[{"id":4627133,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-25T21:17:22.000Z","date":"2026-09-23","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The entire number of shares subject to this option becomes fully vested and exercisable on the first anniversary of the grant date, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date."}],"balance_after":10000,"derivative":{"exercise_price":10.99,"expiration_date":"2036-09-22","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001628280-26-063624","document":"wk-form4_1790371039.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1859810/000162828026063624/wk-form4_1790371039.xml","form_type":"4"}},{"id":747421,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-05T20:28:13.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":115000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award made pursuant to Non-Employee Director Compensation Program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date."}],"balance_after":115000,"derivative":{"exercise_price":0.178,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":115000},"source":{"system":"sec-edgar","filing":"0001859810-26-000003","document":"wk-form4_1780691291.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000185981026000003/wk-form4_1780691291.xml","form_type":"4"}},{"id":758403,"issuer":{"id":2649,"kind":"organization","name":"Spyre Therapeutics, Inc.","symbol":"SYRE"},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-29T21:54:49.000Z","date":"2026-05-27","kind":"grant","planned":false,"acquired":true,"shares":8026,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase 8,026 shares of the Issuer's common stock, which will vest and become fully exercisable upon the earlier of May 27, 2027 or the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through the applicable vesting date."}],"balance_after":8026,"derivative":{"exercise_price":72.51,"expiration_date":"2036-05-27","underlying":"Common Stock","underlying_shares":8026},"source":{"system":"sec-edgar","filing":"0001859810-26-000002","document":"wk-form4_1780091687.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636282/000185981026000002/wk-form4_1780091687.xml","form_type":"4"}},{"id":1059886,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-20T20:04:35.000Z","date":"2025-08-19","kind":"purchase","planned":false,"acquired":true,"shares":26050,"price":1.92,"value":50016.0,"ownership":{"direct":true},"balance_after":58050,"source":{"system":"sec-edgar","filing":"0001728117-25-000072","document":"wk-form4_1755720270.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811725000072/wk-form4_1755720270.xml","form_type":"4"}},{"id":1100785,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-26T20:36:35.000Z","date":"2025-06-25","kind":"grant","planned":false,"acquired":true,"shares":115000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award made pursuant to Non-Employee Director Compensation Program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date."}],"balance_after":115000,"derivative":{"exercise_price":1.36,"expiration_date":"2035-06-24","underlying":"Common Stock","underlying_shares":115000},"source":{"system":"sec-edgar","filing":"0001728117-25-000053","document":"wk-form4_1750970185.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811725000053/wk-form4_1750970185.xml","form_type":"4"}},{"id":1127183,"issuer":{"id":2649,"kind":"organization","name":"Spyre Therapeutics, Inc.","symbol":"SYRE"},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-02T20:37:14.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase 25,000 shares of the Issuer's common stock, which will vest and become exercisable in 12 equal monthly installments following May 29, 2025 until such time as the option is 100% vested, subject to the Reporting Person's continuous service with the Issuer at each vesting date."}],"balance_after":25000,"derivative":{"exercise_price":15.55,"expiration_date":"2035-05-29","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001636282-25-000067","document":"wk-form4_1748896627.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636282/000163628225000067/wk-form4_1748896627.xml","form_type":"4"}},{"id":1292157,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Restricted Stock Units","published_at":"2025-01-29T22:20:58.000Z","date":"2024-12-31","kind":"exercise","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On October 28, 2024, the reporting person was granted 20,000 RSUs, which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On October 28, 2024, the reporting person was granted 20,000 RSUs, which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001859810-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/926617/000185981025000002/primary_doc.xml","form_type":"4/A","original_submission_date":"2025-01-08"}},{"id":1292156,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Common Stock","published_at":"2025-01-29T22:20:58.000Z","date":"2025-01-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":6356,"price":0.7,"value":4449.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This line reflects the tax withholding on the vesting of RSUs that vested on December 31, 2024."},{"field":"kind","element":"transactionCoding","label":"F5","text":"This report is being filed to correct the number of shares held after tax withholding on the vesting of RSUs that vested on December 31, 2024."}],"balance_after":13644,"source":{"system":"sec-edgar","filing":"0001859810-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/926617/000185981025000002/primary_doc.xml","form_type":"4/A","original_submission_date":"2025-01-08"}},{"id":1292155,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Common Stock","published_at":"2025-01-29T22:20:58.000Z","date":"2024-12-31","kind":"exercise","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On October 28, 2024, the reporting person was granted 20,000 RSUs, which vested on December 31, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on October 28, 2024."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001859810-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000185981025000002/primary_doc.xml","form_type":"4/A","original_submission_date":"2025-01-08"}},{"id":1307137,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & President"}}],"security":"Restricted Stock Units","published_at":"2025-01-08T23:35:40.000Z","date":"2024-12-31","kind":"exercise","planned":false,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On October 28, 2024, the reporting person was granted 20,000 RSUs, which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On October 28, 2024, the reporting person was granted 20,000 RSUs, which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001859810-25-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/926617/000185981025000001/primary_doc.xml","form_type":"4"}},{"id":1307136,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & President"}}],"security":"Common Stock","published_at":"2025-01-08T23:35:40.000Z","date":"2024-12-31","kind":"exercise","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On October 28, 2024, the reporting person was granted 20,000 RSUs, which vested on December 31, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on October 28, 2024."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001859810-25-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000185981025000001/primary_doc.xml","form_type":"4"}},{"id":1367288,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock option (right to buy)","published_at":"2024-11-14T01:54:27.000Z","date":"2024-11-12","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25000,"derivative":{"exercise_price":0.84,"exercise_date":"2024-11-12","expiration_date":"2034-11-12","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001859810-24-000005","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000185981024000005/primary_doc.xml","form_type":"4"}},{"id":1380821,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Restricted Stock Units","published_at":"2024-10-28T22:54:49.000Z","date":"2024-10-28","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In accordance with her amended contract effective September 1, 2024, the award will vest 100% on December 31, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"In accordance with her amended contract effective September 1, 2024, the award will vest 100% on December 31, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date."}],"balance_after":20000,"derivative":{"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001859810-24-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000185981024000004/primary_doc.xml","form_type":"4"}},{"id":1488011,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option (Right to Buy)","published_at":"2024-06-07T01:58:31.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":115000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award made pursuant to Non-Employee Director Compensation Program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date."}],"balance_after":115000,"derivative":{"exercise_price":0.6,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":115000},"source":{"system":"sec-edgar","filing":"0001728117-24-000066","document":"wk-form4_1717725502.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811724000066/wk-form4_1717725502.xml","form_type":"4"}},{"id":1513788,"issuer":{"id":2649,"kind":"organization","name":"Spyre Therapeutics, Inc.","symbol":"SYRE"},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-16T20:10:27.000Z","date":"2024-05-14","kind":"grant","planned":false,"acquired":true,"shares":21980,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase 21,980 shares of the Issuer's common stock, which will vest and become exercisable in 36 equal monthly installments following May 14, 2024 until such time as the option is 100% vested, subject to the Reporting Person's continuous service with the Issuer at each vesting date."}],"balance_after":21980,"derivative":{"exercise_price":39.29,"expiration_date":"2034-05-14","underlying":"Common Stock","underlying_shares":21980},"source":{"system":"sec-edgar","filing":"0000950170-24-061083","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636282/000095017024061083/ownership.xml","form_type":"4"}},{"id":1526757,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"EMPLOYEE STOCK OPTION (RIGHT TO BUY)","published_at":"2024-05-06T22:49:30.000Z","date":"2024-05-03","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The employee stock option will vest in four equal annual amounts beginning April 1, 2025."}],"balance_after":30000,"derivative":{"exercise_price":3.21,"expiration_date":"2034-05-03","underlying":"COMMON STOCK","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001859810-24-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000185981024000003/primary_doc.xml","form_type":"4"}},{"id":1735977,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-17T21:01:17.000Z","date":"2023-11-15","kind":"purchase","planned":false,"acquired":true,"shares":32000,"price":0.7879,"value":25212.8,"ownership":{"direct":false,"nature":"By family trust"},"balance_after":32000,"source":{"system":"sec-edgar","filing":"0001728117-23-000138","document":"wk-form4_1700254868.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811723000138/wk-form4_1700254868.xml","form_type":"4"}},{"id":1859971,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-09T20:14:43.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award made pursuant to Non-Employee Director Compensation Program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date."}],"balance_after":35000,"derivative":{"exercise_price":1.26,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001728117-23-000082","document":"wf-form4_168634167292261.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811723000082/wf-form4_168634167292261.xml","form_type":"4"}},{"id":1900584,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Research & Development"}}],"security":"Restricted Stock Units","published_at":"2023-05-08T22:43:51.000Z","date":"2023-05-04","kind":"exercise","planned":false,"acquired":false,"shares":4984,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"1. The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU. On each of May 4, 2022 and May 4, 2023, one-third of the RSUs vested, with the remaining RSUs to vest on May 4, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1. The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU. On each of May 4, 2022 and May 4, 2023, one-third of the RSUs vested, with the remaining RSUs to vest on May 4, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"1. The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU. On each of May 4, 2022 and May 4, 2023, one-third of the RSUs vested, with the remaining RSUs to vest on May 4, 2024."}],"balance_after":4984,"derivative":{"exercise_date":"2023-05-04","expiration_date":"2024-05-04","underlying":"Common Stock","underlying_shares":4989},"source":{"system":"sec-edgar","filing":"0001209191-23-028100","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000120919123028100/doc4.xml","form_type":"4"}},{"id":1900583,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Research & Development"}}],"security":"Common Stock","published_at":"2023-05-08T22:43:51.000Z","date":"2023-05-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":2168,"price":24.24,"value":52552.32,"ownership":{"direct":true},"balance_after":28599,"source":{"system":"sec-edgar","filing":"0001209191-23-028100","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000120919123028100/doc4.xml","form_type":"4"}},{"id":1900582,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Research & Development"}}],"security":"Common Stock","published_at":"2023-05-08T22:43:51.000Z","date":"2023-05-04","kind":"exercise","planned":false,"acquired":true,"shares":4984,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1. The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU. On each of May 4, 2022 and May 4, 2023, one-third of the RSUs vested, with the remaining RSUs to vest on May 4, 2024."}],"balance_after":30767,"source":{"system":"sec-edgar","filing":"0001209191-23-028100","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000120919123028100/doc4.xml","form_type":"4"}},{"id":1905431,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Research & Development"}}],"security":"Restricted Stock Units","published_at":"2023-05-03T23:06:56.000Z","date":"2023-05-01","kind":"exercise","planned":false,"acquired":false,"shares":1899,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU. On May 1, 2022, 50% of the RSUs vested, and on May 1, 2023, the remaining 50% of the RSUs vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU. On May 1, 2022, 50% of the RSUs vested, and on May 1, 2023, the remaining 50% of the RSUs vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU. On May 1, 2022, 50% of the RSUs vested, and on May 1, 2023, the remaining 50% of the RSUs vested."}],"balance_after":0,"derivative":{"exercise_date":"2023-05-01","expiration_date":"2023-05-01","underlying":"Common Stock","underlying_shares":1899},"source":{"system":"sec-edgar","filing":"0001209191-23-027173","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000120919123027173/doc4.xml","form_type":"4"}},{"id":1905430,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Research & Development"}}],"security":"Common Stock","published_at":"2023-05-03T23:06:56.000Z","date":"2023-05-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":826,"price":24.63,"value":20344.38,"ownership":{"direct":true},"balance_after":25783,"source":{"system":"sec-edgar","filing":"0001209191-23-027173","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000120919123027173/doc4.xml","form_type":"4"}},{"id":1905429,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Research & Development"}}],"security":"Common Stock","published_at":"2023-05-03T23:06:56.000Z","date":"2023-05-01","kind":"exercise","planned":false,"acquired":true,"shares":1899,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU. On May 1, 2022, 50% of the RSUs vested, and on May 1, 2023, the remaining 50% of the RSUs vested."}],"balance_after":26609,"source":{"system":"sec-edgar","filing":"0001209191-23-027173","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000120919123027173/doc4.xml","form_type":"4"}},{"id":1926444,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Research & Development"}}],"security":"Stock Option (right to buy)","published_at":"2023-04-05T00:18:19.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":104961,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Reporting Person was granted stock options, which vest and become exercisable in three equal installments on March 31, 2024, March 31, 2025 and March 31, 2026."}],"balance_after":104961,"derivative":{"exercise_price":23.52,"exercise_date":"2024-03-31","expiration_date":"2033-03-31","underlying":"Common Stock","underlying_shares":104961},"source":{"system":"sec-edgar","filing":"0001209191-23-023078","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000120919123023078/doc4.xml","form_type":"4"}},{"id":1926443,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Research & Development"}}],"security":"Restricted Stock Units","published_at":"2023-04-05T00:18:19.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":29230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon common stock for each RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These RSUs vest and are distributed as shares of Organon common stock in three equal installments on March 31, 2024, March 31, 2025 and March 31, 2026."}],"balance_after":29230,"derivative":{"exercise_date":"2024-03-31","expiration_date":"2026-03-31","underlying":"Common Stock","underlying_shares":29230},"source":{"system":"sec-edgar","filing":"0001209191-23-023078","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000120919123023078/doc4.xml","form_type":"4"}},{"id":1926442,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Research & Development"}}],"security":"Restricted Stock Units","published_at":"2023-04-05T00:18:19.000Z","date":"2023-03-31","kind":"exercise","planned":false,"acquired":false,"shares":5964,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit converts into one share of Organon & Co. (\"Organon\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 31, 2023, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on March 31, 2024 and March 31, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 31, 2023, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on March 31, 2024 and March 31, 2025."}],"balance_after":11928,"derivative":{"underlying":"Common Stock","underlying_shares":5964},"source":{"system":"sec-edgar","filing":"0001209191-23-023078","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000120919123023078/doc4.xml","form_type":"4"}},{"id":1926441,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Research & Development"}}],"security":"Common Stock","published_at":"2023-04-05T00:18:19.000Z","date":"2023-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":2115,"price":23.09,"value":48835.35,"ownership":{"direct":true},"balance_after":24710,"source":{"system":"sec-edgar","filing":"0001209191-23-023078","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000120919123023078/doc4.xml","form_type":"4"}},{"id":1926440,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Research & Development"}}],"security":"Common Stock","published_at":"2023-04-05T00:18:19.000Z","date":"2023-03-31","kind":"exercise","planned":false,"acquired":true,"shares":5964,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":26825,"source":{"system":"sec-edgar","filing":"0001209191-23-023078","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000120919123023078/doc4.xml","form_type":"4"}},{"id":1978326,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Research & Development"}}],"security":"Restricted Stock Units","published_at":"2023-03-02T22:29:42.000Z","date":"2023-02-28","kind":"exercise","acquired":false,"shares":7976,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit converts into one share of Organon & Co. common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"As originally reported on the Form 4, dated June 4, 2021, these Restricted Stock Units vested on December 31, 2022. These Restricted Stock Units were subsequently distributed to the Reporting Person on February 28, 2023."},{"field":"shares","element":"transactionShares","label":"F3","text":"The amount of Restricted Stock Units has been slightly adjusted from the Reporting Person's Form 4, dated June 4, 2021, based on the finalization of certain calculations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"As originally reported on the Form 4, dated June 4, 2021, these Restricted Stock Units vested on December 31, 2022. These Restricted Stock Units were subsequently distributed to the Reporting Person on February 28, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"As originally reported on the Form 4, dated June 4, 2021, these Restricted Stock Units vested on December 31, 2022. These Restricted Stock Units were subsequently distributed to the Reporting Person on February 28, 2023."}],"balance_after":0,"derivative":{"exercise_date":"2022-12-31","expiration_date":"2022-12-31","underlying":"Common Stock","underlying_shares":7976},"source":{"system":"sec-edgar","filing":"0001209191-23-014842","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000120919123014842/doc4.xml","form_type":"4"}},{"id":1978325,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Research & Development"}}],"security":"Common Stock","published_at":"2023-03-02T22:29:42.000Z","date":"2023-02-28","kind":"tax_withholding","acquired":false,"shares":2346,"price":25.09,"value":58861.14,"ownership":{"direct":true},"balance_after":20861,"source":{"system":"sec-edgar","filing":"0001209191-23-014842","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000120919123014842/doc4.xml","form_type":"4"}},{"id":1978324,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Research & Development"}}],"security":"Common Stock","published_at":"2023-03-02T22:29:42.000Z","date":"2023-02-28","kind":"exercise","acquired":true,"shares":7976,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit converts into one share of Organon & Co. common stock."}],"balance_after":23207,"source":{"system":"sec-edgar","filing":"0001209191-23-014842","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000120919123014842/doc4.xml","form_type":"4"}},{"id":2206874,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-15T21:03:57.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award made pursuant to Non-Employee Director Compensation Program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date"}],"balance_after":30000,"derivative":{"exercise_price":7.02,"expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001728117-22-000069","document":"wf-form4_165791902180593.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811722000069/wf-form4_165791902180593.xml","form_type":"4"}},{"id":2280436,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Research & Development"}}],"security":"Restricted Stock Units","published_at":"2022-05-06T00:47:48.000Z","date":"2022-05-04","kind":"exercise","acquired":false,"shares":4984,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU."},{"field":"shares","element":"transactionShares","label":"F2","text":"The amount of the RSUs has been slightly adjusted from the Reporting Person's Form 4, dated June 4, 2021, based on the finalization of certain calculations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On May 4, 2022, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on May 4, 2023 and May 4, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On May 4, 2022, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on May 4, 2023 and May 4, 2024."}],"balance_after":4984,"derivative":{"exercise_date":"2022-05-04","expiration_date":"2024-05-04","underlying":"Common Stock","underlying_shares":4984},"source":{"system":"sec-edgar","filing":"0001104659-22-056628","document":"tm2214603-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000110465922056628/tm2214603-4_4seq1.xml","form_type":"4"}},{"id":2280435,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Research & Development"}}],"security":"Restricted Stock Units","published_at":"2022-05-06T00:47:48.000Z","date":"2022-05-03","kind":"exercise","acquired":false,"shares":1842,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU."}],"balance_after":1842,"derivative":{"exercise_date":"2022-05-03","expiration_date":"2022-05-03","underlying":"Common Stock","underlying_shares":1842},"source":{"system":"sec-edgar","filing":"0001104659-22-056628","document":"tm2214603-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000110465922056628/tm2214603-4_4seq1.xml","form_type":"4"}},{"id":2280434,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Research & Development"}}],"security":"Common Stock","published_at":"2022-05-06T00:47:48.000Z","date":"2022-05-04","kind":"tax_withholding","acquired":false,"shares":1806,"price":32.44,"value":58586.64,"ownership":{"direct":true},"balance_after":15231,"source":{"system":"sec-edgar","filing":"0001104659-22-056628","document":"tm2214603-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000110465922056628/tm2214603-4_4seq1.xml","form_type":"4"}},{"id":2280433,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Research & Development"}}],"security":"Common Stock","published_at":"2022-05-06T00:47:48.000Z","date":"2022-05-04","kind":"exercise","acquired":true,"shares":4984,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU."}],"balance_after":17037,"source":{"system":"sec-edgar","filing":"0001104659-22-056628","document":"tm2214603-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000110465922056628/tm2214603-4_4seq1.xml","form_type":"4"}},{"id":2280432,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Research & Development"}}],"security":"Common Stock","published_at":"2022-05-06T00:47:48.000Z","date":"2022-05-03","kind":"tax_withholding","acquired":false,"shares":525,"price":32.08,"value":16842.0,"ownership":{"direct":true},"balance_after":12053,"source":{"system":"sec-edgar","filing":"0001104659-22-056628","document":"tm2214603-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000110465922056628/tm2214603-4_4seq1.xml","form_type":"4"}},{"id":2280431,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Research & Development"}}],"security":"Common Stock","published_at":"2022-05-06T00:47:48.000Z","date":"2022-05-03","kind":"exercise","acquired":true,"shares":1842,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU."}],"balance_after":12578,"source":{"system":"sec-edgar","filing":"0001104659-22-056628","document":"tm2214603-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000110465922056628/tm2214603-4_4seq1.xml","form_type":"4"}},{"id":2283658,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Research & Development"}}],"security":"Restricted Stock Units","published_at":"2022-05-03T23:40:19.000Z","date":"2022-05-01","kind":"exercise","acquired":false,"shares":1896,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU. On May 1, 2022, 50% of the RSUs vested with the remaining 50% of the RSUs to vest on May 1, 2023."},{"field":"shares","element":"transactionShares","label":"F2","text":"The amount of the RSUs has been slightly adjusted from the Reporting Person's Form 4, dated June 4, 2021, based on the finalization of certain calculations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU. On May 1, 2022, 50% of the RSUs vested with the remaining 50% of the RSUs to vest on May 1, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU. On May 1, 2022, 50% of the RSUs vested with the remaining 50% of the RSUs to vest on May 1, 2023."}],"balance_after":1896,"derivative":{"exercise_date":"2022-05-01","expiration_date":"2023-05-01","underlying":"Common Stock","underlying_shares":1896},"source":{"system":"sec-edgar","filing":"0001104659-22-055430","document":"tm2214297-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000110465922055430/tm2214297-4_4seq1.xml","form_type":"4"}},{"id":2283657,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Research & Development"}}],"security":"Common Stock","published_at":"2022-05-03T23:40:19.000Z","date":"2022-05-01","kind":"tax_withholding","acquired":false,"shares":540,"price":32.33,"value":17458.2,"ownership":{"direct":true},"balance_after":10736,"source":{"system":"sec-edgar","filing":"0001104659-22-055430","document":"tm2214297-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000110465922055430/tm2214297-4_4seq1.xml","form_type":"4"}},{"id":2283656,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Research & Development"}}],"security":"Common Stock","published_at":"2022-05-03T23:40:19.000Z","date":"2022-05-01","kind":"exercise","acquired":true,"shares":1896,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU. On May 1, 2022, 50% of the RSUs vested with the remaining 50% of the RSUs to vest on May 1, 2023."}],"balance_after":11276,"source":{"system":"sec-edgar","filing":"0001104659-22-055430","document":"tm2214297-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000110465922055430/tm2214297-4_4seq1.xml","form_type":"4"}},{"id":2306977,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Research & Development"}}],"security":"Stock Option (right to buy)","published_at":"2022-04-04T22:06:52.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":55114,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Reporting Person was granted stock options, which vest and become exercisable in three equal installments on March 31, 2023, March 31, 2024 and March 31, 2025."}],"balance_after":55114,"derivative":{"exercise_price":34.93,"exercise_date":"2023-03-31","expiration_date":"2032-03-29","underlying":"Common Stock","underlying_shares":55114},"source":{"system":"sec-edgar","filing":"0001104659-22-042359","document":"tm2211465-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000110465922042359/tm2211465-4_4seq1.xml","form_type":"4"}},{"id":2306976,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Research & Development"}}],"security":"Restricted Stock Units","published_at":"2022-04-04T22:06:52.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":17892,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs vest and are distributed as shares of Organon common stock in three equal installments on March 31, 2023, March 31, 2024 and March 31, 2025."}],"balance_after":17892,"derivative":{"exercise_date":"2023-03-31","expiration_date":"2025-03-31","underlying":"Common Stock","underlying_shares":17892},"source":{"system":"sec-edgar","filing":"0001104659-22-042359","document":"tm2211465-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000110465922042359/tm2211465-4_4seq1.xml","form_type":"4"}},{"id":2359178,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Research & Development"}}],"security":"Restricted Stock Units","published_at":"2022-03-02T23:46:39.000Z","date":"2022-02-28","kind":"exercise","acquired":false,"shares":10171,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit converts into one share of Organon & Co. common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"As originally reported on the Form 4, dated June 4, 2021, these Restricted Stock Units vested on December 31, 2021. These Restricted Stock Units were subsequently distributed to the Reporting Person on February 28, 2022."},{"field":"shares","element":"transactionShares","label":"F3","text":"The amount of the Restricted Stock Units has been slightly adjusted from the Reporting Person's Form 4, dated June 4, 2021, based on the finalization of certain calculations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"As originally reported on the Form 4, dated June 4, 2021, these Restricted Stock Units vested on December 31, 2021. These Restricted Stock Units were subsequently distributed to the Reporting Person on February 28, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"As originally reported on the Form 4, dated June 4, 2021, these Restricted Stock Units vested on December 31, 2021. These Restricted Stock Units were subsequently distributed to the Reporting Person on February 28, 2022."}],"balance_after":0,"derivative":{"exercise_date":"2021-12-31","expiration_date":"2021-12-31","underlying":"Common Stock","underlying_shares":10171},"source":{"system":"sec-edgar","filing":"0001104659-22-029457","document":"tm228175-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000110465922029457/tm228175-5_4seq1.xml","form_type":"4"}},{"id":2359177,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Research & Development"}}],"security":"Common Stock","published_at":"2022-03-02T23:46:39.000Z","date":"2022-02-28","kind":"tax_withholding","acquired":false,"shares":2941,"price":37.57,"value":110493.37,"ownership":{"direct":true},"balance_after":9380,"source":{"system":"sec-edgar","filing":"0001104659-22-029457","document":"tm228175-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000110465922029457/tm228175-5_4seq1.xml","form_type":"4"}},{"id":2359176,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Research & Development"}}],"security":"Common Stock","published_at":"2022-03-02T23:46:39.000Z","date":"2022-02-28","kind":"exercise","acquired":true,"shares":10171,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit converts into one share of Organon & Co. common stock."}],"balance_after":12321,"source":{"system":"sec-edgar","filing":"0001104659-22-029457","document":"tm228175-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000110465922029457/tm228175-5_4seq1.xml","form_type":"4"}},{"id":2595721,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Research & Development"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-19T21:14:14.000Z","date":"2021-08-17","kind":"grant","acquired":true,"shares":22321,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in three equal installments on August 17, 2022, August 17, 2023 and August 17, 2024."}],"balance_after":22321,"derivative":{"exercise_price":35.38,"exercise_date":"2022-08-17","expiration_date":"2031-08-16","underlying":"Common Stock","underlying_shares":22321},"source":{"system":"sec-edgar","filing":"0000899243-21-033677","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000089924321033677/doc4.xml","form_type":"4"}},{"id":2669599,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-14T21:26:44.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":47000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Corporation on each such vesting date."}],"balance_after":47000,"derivative":{"exercise_price":8.93,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":47000},"source":{"system":"sec-edgar","filing":"0001728117-21-000074","document":"wf-form4_162370598998133.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811721000074/wf-form4_162370598998133.xml","form_type":"4"}},{"id":2680346,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Research & Development"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-05T01:27:31.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":115980,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"In connection with the Separation, each outstanding Merck stock option was converted into an award of options to purchase shares of Organon common stock pursuant to the terms of the employee matters agreement between Merck and Organon. The number of shares and exercise price of each option award was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Merck stock option. The value reflects Organon's best estimate of the numbers using the currently available information and may be subject to adjustment following finalization of calculations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"The option vests and becomes exercisable in three equal installments on May 4, 2022, May 4, 2023 and May 4, 2024."}],"balance_after":115980,"derivative":{"exercise_price":36.11,"exercise_date":"2022-05-04","expiration_date":"2031-05-03","underlying":"Common Stock","underlying_shares":115980},"source":{"system":"sec-edgar","filing":"0000899243-21-022200","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000089924321022200/doc4.xml","form_type":"4"}},{"id":2680345,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Research & Development"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-05T01:27:31.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":44503,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"In connection with the Separation, each outstanding Merck stock option was converted into an award of options to purchase shares of Organon common stock pursuant to the terms of the employee matters agreement between Merck and Organon. The number of shares and exercise price of each option award was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Merck stock option. The value reflects Organon's best estimate of the numbers using the currently available information and may be subject to adjustment following finalization of calculations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"14,834 shares underlying the option are fully vested. The remaining shares vest and become exercisable in two equal installments on May 1, 2022 and May 1, 2023."}],"balance_after":44503,"derivative":{"exercise_price":36.91,"exercise_date":"2022-05-01","expiration_date":"2030-04-30","underlying":"Common Stock","underlying_shares":44503},"source":{"system":"sec-edgar","filing":"0000899243-21-022200","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000089924321022200/doc4.xml","form_type":"4"}},{"id":2680344,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Research & Development"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-05T01:27:31.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":41588,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"In connection with the Separation, each outstanding Merck stock option was converted into an award of options to purchase shares of Organon common stock pursuant to the terms of the employee matters agreement between Merck and Organon. The number of shares and exercise price of each option award was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Merck stock option. The value reflects Organon's best estimate of the numbers using the currently available information and may be subject to adjustment following finalization of calculations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"27,724 shares underlying the option are fully vested. The remaining shares vest and become exercisable on May 3, 2022."}],"balance_after":41588,"derivative":{"exercise_price":38.01,"exercise_date":"2022-05-03","expiration_date":"2029-05-02","underlying":"Common Stock","underlying_shares":41588},"source":{"system":"sec-edgar","filing":"0000899243-21-022200","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000089924321022200/doc4.xml","form_type":"4"}},{"id":2680343,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Research & Development"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-05T01:27:31.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":53919,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"In connection with the Separation, each outstanding Merck stock option was converted into an award of options to purchase shares of Organon common stock pursuant to the terms of the employee matters agreement between Merck and Organon. The number of shares and exercise price of each option award was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Merck stock option. The value reflects Organon's best estimate of the numbers using the currently available information and may be subject to adjustment following finalization of calculations."}],"balance_after":53919,"derivative":{"exercise_price":27.44,"exercise_date":"2021-06-02","expiration_date":"2028-05-03","underlying":"Common Stock","underlying_shares":53919},"source":{"system":"sec-edgar","filing":"0000899243-21-022200","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000089924321022200/doc4.xml","form_type":"4"}},{"id":2680342,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Research & Development"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-05T01:27:31.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":63054,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"In connection with the Separation, each outstanding Merck stock option was converted into an award of options to purchase shares of Organon common stock pursuant to the terms of the employee matters agreement between Merck and Organon. The number of shares and exercise price of each option award was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Merck stock option. The value reflects Organon's best estimate of the numbers using the currently available information and may be subject to adjustment following finalization of calculations."}],"balance_after":63054,"derivative":{"exercise_price":30.4,"exercise_date":"2021-06-02","expiration_date":"2027-05-04","underlying":"Common Stock","underlying_shares":63054},"source":{"system":"sec-edgar","filing":"0000899243-21-022200","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000089924321022200/doc4.xml","form_type":"4"}},{"id":2680341,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Research & Development"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-05T01:27:31.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":48931,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"In connection with the Separation, each outstanding Merck stock option was converted into an award of options to purchase shares of Organon common stock pursuant to the terms of the employee matters agreement between Merck and Organon. The number of shares and exercise price of each option award was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Merck stock option. The value reflects Organon's best estimate of the numbers using the currently available information and may be subject to adjustment following finalization of calculations."}],"balance_after":48931,"derivative":{"exercise_price":25.98,"exercise_date":"2021-06-02","expiration_date":"2026-05-09","underlying":"Common Stock","underlying_shares":48931},"source":{"system":"sec-edgar","filing":"0000899243-21-022200","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000089924321022200/doc4.xml","form_type":"4"}},{"id":2680340,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Research & Development"}}],"security":"Restricted Stock Units","published_at":"2021-06-05T01:27:31.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":19828,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Organon common stock."},{"field":"kind","element":"transactionCoding","label":"F6","text":"In connection with the Separation, each outstanding Merck performance stock unit award was converted into a restricted stock unit award denominated in shares of Organon common stock pursuant to the terms of the employee matters agreement between Merck and Organon. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Merck performance stock unit award. The value reflects Organon's best estimate of the numbers using the currently available information and may be subject to adjustment following finalization of calculations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"These restricted stock units vest and are distributed as shares of Organon common stock in a single installment on December 31, 2023."}],"balance_after":19828,"derivative":{"exercise_date":"2023-12-31","expiration_date":"2023-12-31","underlying":"Common Stock","underlying_shares":19828},"source":{"system":"sec-edgar","filing":"0000899243-21-022200","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000089924321022200/doc4.xml","form_type":"4"}},{"id":2680339,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Research & Development"}}],"security":"Restricted Stock Units","published_at":"2021-06-05T01:27:31.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":7975,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Organon common stock."},{"field":"kind","element":"transactionCoding","label":"F6","text":"In connection with the Separation, each outstanding Merck performance stock unit award was converted into a restricted stock unit award denominated in shares of Organon common stock pursuant to the terms of the employee matters agreement between Merck and Organon. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Merck performance stock unit award. The value reflects Organon's best estimate of the numbers using the currently available information and may be subject to adjustment following finalization of calculations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"These restricted stock units vest and are distributed as shares of Organon common stock in a single installment on December 31, 2022."}],"balance_after":7975,"derivative":{"exercise_date":"2022-12-31","expiration_date":"2022-12-31","underlying":"Common Stock","underlying_shares":7975},"source":{"system":"sec-edgar","filing":"0000899243-21-022200","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000089924321022200/doc4.xml","form_type":"4"}},{"id":2680338,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Research & Development"}}],"security":"Restricted Stock Units","published_at":"2021-06-05T01:27:31.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":10170,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Organon common stock."},{"field":"kind","element":"transactionCoding","label":"F6","text":"In connection with the Separation, each outstanding Merck performance stock unit award was converted into a restricted stock unit award denominated in shares of Organon common stock pursuant to the terms of the employee matters agreement between Merck and Organon. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Merck performance stock unit award. The value reflects Organon's best estimate of the numbers using the currently available information and may be subject to adjustment following finalization of calculations."}],"balance_after":10170,"derivative":{"exercise_date":"2021-12-31","expiration_date":"2021-12-31","underlying":"Common Stock","underlying_shares":10170},"source":{"system":"sec-edgar","filing":"0000899243-21-022200","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000089924321022200/doc4.xml","form_type":"4"}},{"id":2680337,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Research & Development"}}],"security":"Restricted Stock Units","published_at":"2021-06-05T01:27:31.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":14957,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Organon common stock."},{"field":"kind","element":"transactionCoding","label":"F3","text":"In connection with the Separation, each outstanding Merck restricted stock unit award was converted into a restricted stock unit award denominated in shares of Organon common stock pursuant to the terms of the employee matters agreement between Merck and Organon. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Merck restricted stock unit award. The value reflects Organon's best estimate of the numbers using the currently available information and may be subject to adjustment following finalization of calculations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These restricted stock units vest and are distributed as shares of Organon common stock in three equal installments on May 4, 2022, May 4, 2023 and May 4, 2024."}],"balance_after":14957,"derivative":{"exercise_date":"2022-05-04","expiration_date":"2024-05-04","underlying":"Common Stock","underlying_shares":14957},"source":{"system":"sec-edgar","filing":"0000899243-21-022200","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000089924321022200/doc4.xml","form_type":"4"}},{"id":2680336,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Research & Development"}}],"security":"Restricted Stock Units","published_at":"2021-06-05T01:27:31.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":3795,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Organon common stock."},{"field":"kind","element":"transactionCoding","label":"F3","text":"In connection with the Separation, each outstanding Merck restricted stock unit award was converted into a restricted stock unit award denominated in shares of Organon common stock pursuant to the terms of the employee matters agreement between Merck and Organon. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Merck restricted stock unit award. The value reflects Organon's best estimate of the numbers using the currently available information and may be subject to adjustment following finalization of calculations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These restricted stock units vest and are distributed as shares of Organon common stock in two equal installments on May 1, 2022 and May 1, 2023."}],"balance_after":3795,"derivative":{"exercise_date":"2022-05-01","expiration_date":"2023-05-01","underlying":"Common Stock","underlying_shares":3795},"source":{"system":"sec-edgar","filing":"0000899243-21-022200","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000089924321022200/doc4.xml","form_type":"4"}},{"id":2680335,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":40792,"kind":"person","name":"Milligan Sandra","position":1,"cik":"0001859810","reported_name":"Milligan Sandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Research & Development"}}],"security":"Restricted Stock Units","published_at":"2021-06-05T01:27:31.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":1842,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Organon common stock."},{"field":"kind","element":"transactionCoding","label":"F3","text":"In connection with the Separation, each outstanding Merck restricted stock unit award was converted into a restricted stock unit award denominated in shares of Organon common stock pursuant to the terms of the employee matters agreement between Merck and Organon. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Merck restricted stock unit award. The value reflects Organon's best estimate of the numbers using the currently available information and may be subject to adjustment following finalization of calculations."}],"balance_after":1842,"derivative":{"exercise_date":"2022-05-03","expiration_date":"2022-05-03","underlying":"Common Stock","underlying_shares":1842},"source":{"system":"sec-edgar","filing":"0000899243-21-022200","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000089924321022200/doc4.xml","form_type":"4"}}]}